Artwork

Content provided by Cameron Borg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cameron Borg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

John Mitrofanis: Biophotons, Internal Melanins & Photobiomodulation

51:15
 
Share
 

Manage episode 435957729 series 3595107
Content provided by Cameron Borg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cameron Borg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

John Mitrofanis, PhD, is a world leading researcher on the impact of photobiomodulation and neurodegenerative disease. His work has been centred around seeking effective drug-free treatments and preventative measures for Parkinson’s and Alzheimer’s disease. A former professor of anatomy at the University of Sydney, John is now based in France, where he works at the biomedical research centre, Clinatec in Grenoble France. John is beginning exciting work on biophoton release, examining how photobiomodulation might alter the release of these photons from neurones and other cell types. In his book, Run in the Light, John outlines the most current understanding of the pathologies involved in Parkinson's disease, and how both exercise and photobiomodulation can be used as inexpensive, simple and essentially no-risk modalities to both prevent and delay the progression of the disease. John is extremely humble and open-minded; excellent qualities to explore deep scientific questions.

Listen to our previous conversation

John's Work

- Run In The Light Book

- Why and how does light therapy offer neuroprotection in Parkinson's disease?

- Does photobiomodulation require glucose to work effectively?

My Work

Website

Consultation

Instagram

Youtube

Spotify

Apple Podcasts

Linktree

  continue reading

57 episodes

Artwork
iconShare
 
Manage episode 435957729 series 3595107
Content provided by Cameron Borg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cameron Borg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

John Mitrofanis, PhD, is a world leading researcher on the impact of photobiomodulation and neurodegenerative disease. His work has been centred around seeking effective drug-free treatments and preventative measures for Parkinson’s and Alzheimer’s disease. A former professor of anatomy at the University of Sydney, John is now based in France, where he works at the biomedical research centre, Clinatec in Grenoble France. John is beginning exciting work on biophoton release, examining how photobiomodulation might alter the release of these photons from neurones and other cell types. In his book, Run in the Light, John outlines the most current understanding of the pathologies involved in Parkinson's disease, and how both exercise and photobiomodulation can be used as inexpensive, simple and essentially no-risk modalities to both prevent and delay the progression of the disease. John is extremely humble and open-minded; excellent qualities to explore deep scientific questions.

Listen to our previous conversation

John's Work

- Run In The Light Book

- Why and how does light therapy offer neuroprotection in Parkinson's disease?

- Does photobiomodulation require glucose to work effectively?

My Work

Website

Consultation

Instagram

Youtube

Spotify

Apple Podcasts

Linktree

  continue reading

57 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide